Avoro Capital Advisors LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Arrowhead Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (ARWR)

Filing Manager: Avoro Capital Advisors LLC
Reporting Manager: Avoro Capital Advisors LLC
Security: Arrowhead Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol: ARWR
Shares outstanding: 125,297,417 shares
Disclosed Ownership: 12,028,552 shares
Ownership: 9.6%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 09:31:24 UTC
Date of event: 31 Dec 2024
Next filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Avoro Capital Advisors LLC	9.6%	12,028,552	12,028,552	0	/s/ Scott Epstein	Scott Epstein, Chief Financial Officer & Chief Compliance Officer
Behzad Aghazadeh	9.6%	12,028,552	12,028,552	0	/s/ Behzad Aghazadeh	Behzad Aghazadeh, Individually